Within just a few months after Beovu’s introduction, some patients began to complain about vision issues. Eye specialists noted that patients were showing signs of a condition known as retinal vasculitis. This condition is caused by the inflammation of the vascular branches of the retinal artery. Symptoms included blurred vision, dark spots in vision, difficulty distinguishing colors and distorted images, among other vision issues.
While the drug maker initially defended its drug in March of 2020, in June of 2020, they made a change to the warning label on the drug’s box, now including retinal vasculitis. However, by this time, patients were exposed to the unannounced dangers of Beovu from October of 2019 until July of 2020. With this in mind, Beovu lawyers began filing lawsuits on behalf of affected patients within that timeframe.